Circulogene today announced the national launch of OncoGenDx, an innovative tissue-based comprehensive genomic profiling (CGP ...
The results of the TROPION-Breast02 trial of the TROP2-targeting antibody-drug conjugate (ADC) were originally due to be ...
ES-SCLC accounts for the majority of small-cell lung cancer diagnoses and is characterized by rapid progression and poor ...
One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK ...
MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively ...
—In an international study, a deep learning model, dubbed Deep-IO, showed a strong capability to predict clinical outcomes of immune checkpoint inhibitor therapy for patients with advanced non-small ...
News-Medical.Net on MSN
Engineered CAR-NK cells show enhanced cancer killing and immune evasion
One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be ...
From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.
Immune checkpoint proteins — proteins that help regulate immune response — were elevated on T-cells and in the blood of ...
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte ...
Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback